Foundation Funds Video to Help Raise Awareness of How NCPDP and Pharmacists Are Filling Gaps in Patient Care
The NCPDP Foundation has just launched a new public service video that shows how NCPDP is supporting pharmacist-led COVID-19 testing…and hopefully soon, vaccine administration. The intent of the video is to raise awareness among policymakers and industry leaders of how NCPDP is working with pharmacists to help fill gaps in patient care.
Foundation donors made it possible to produce this video. You can help support efforts like this by becoming a 1977 Society Donor. Read More.
NCPDP Foundation Seeking Grant Proposals For Pharmacist electronic Care Plan (PeCP) Project
The NCPDP Foundation is seeking to award a co-funded grant between $50,000-$100,000 to fund a proof of concept pilot research project to demonstrate the clinical value of the HL7/NCPDP Pharmacist eCare Plan in the HL7 FHIR format. The Pharmacist eCare Plan (PeCP) standard allows for pharmacist-level monitoring and reporting of medication adherence, health assessments, conveyance of lab results, payment opportunities
and other activities related to a patient's plan of care and connects pharmacists with the patients' broader
healthcare team. Read More
NCPDP Foundation Awards $100,000 to Support Real-Time Prescription Benefit (RTPB) Standard Projects at DrFirst and Johns Hopkins Medicine
The NCPDP Foundation Board of Trustees, who govern the 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, has approved $100,000 in funding to support two research projects piloting the Beta version of NCPDP’s Real-Time Prescription Benefit (RTPB) Standard.
Read More
Call for Grant Proposals for Real-time Prescription Benefit Research Project
The NCPDP Foundation is interested in awarding a grant of up to $50,000 to fund a proof of concept pilot research project on the BETA version NCPDP Real-Time Prescription Benefit (RTPB) Standard. The BETA Standard was approved by NCPDP members during the recent NCPDP Joint Technical Work Group Meetings. Grant proposals are due to the Foundation by September 30, 2019, with an announcement of the grant award to be made by November 30, 2019. Read More
NCPDP Foundation Names Former U.S. Rear Admiral Pam Schweitzer to its Board of Trustees
The NCPDP Foundation, a 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, announced today that former Assistant Surgeon General and Chief Pharmacist of the U.S. Public Health Service (PHS), Rear Admiral (RADM) Pam Schweitzer, Pharm.D., will join its NCPDP Foundation Board effectively immediately. Read More
Johns Hopkins Study Affirms Benefit of CancelRx and Leads to Enhancements
A Johns Hopkins Medicine study, funded by a $42,000 NCPDP Foundation grant, affirms the important function of the CancelRx ePrescribing transaction in decreasing adverse patient events due to medication errors, and will lead to the transaction becoming even more valuable in improving patient safety. CancelRx is an underused transaction in the NCPDP SCRIPT Standard for ePrescribing that enables prescribers to electronically cancel a prescription already submitted to a pharmacy. Read More
New Grant Helps Advance Pharmacist eCare Plan
The Foundation recently approved a $25,000 grant to the NCPA Innovation Center to help support further development of the Pharmacist eCare Plan and its adoption as a national standard. WG10 Professional Pharmacy Services initially developed the Pharmacist eCare Plan to enable pharmacists to capture their assessments of patient health status and health concerns, mutually defined patient care goals, recommendations, interventions and outcomes and to share them with other care providers, payers and the patient.
NCPDP Grant Will Demonstrate Impact of CancelRx with Controlled Substance Prescriptions
Another NCPDP Foundation grant of $36,000 to the University of Wisconsin-Madison, School of Pharmacy will demonstrate how the use of CancelRx impacts the cancellation and dispensing of controlled substance prescriptions. Use of the Cancel Rx electronic transaction can potentially minimize the number of extraneous or unnecessary controlled substance medications that are dispensed and available to patients, thereby helping to abate the opioid crisis.
Foundation Receives $1 Million Mary and Charles D. Pulido Endowment
The Foundation recently received a $1,000,000 endowment from NCPDP in honor of Mary and Charles D. Pulido. Charlie is the sole surviving co-founder of NCPDP and a founding Board member of the NCPDP Foundation. For more than 40 years, Charlie has been a passionate supporter and valued ambassador for NCPDP and now the NCPDP Foundation. Charlie and his wife, Mary, have personally donated generously to the Foundation. The endowment is a restricted fund intended to help sustain the Foundation in the long run. The principal cannot be touched -- however a percent of the interest can be used to support the Foundation’s work. The intention is for the principal to continue to grow and help ensure that the Foundation endures so its work will continue in perpetuity.
1977 Society Launches with 31 Inaugural Donors and $61,287
The Foundation announced its new 1977 Society annual giving donor program on May 7 during the NCPDP Annual Conference in Scottsdale, Arizona. The Society recognizes donors who support the Vision and Purpose of the NCPDP Foundation by providing monetary donations totaling $1,977 or more within a calendar year. Read More
2019 Annual Fund Campaign Exceeds Expectations
Our first Annual Fund Giving Campaign has exceeded expectations – a sign that prospective donors are learning more about the NCPDP Foundation and potential value of projects funded through donations to the Foundation. We had hoped to reach 50% of the $100,000 goal for the 2019 Annual Fund Campaign by the end of NCPDP’s Annual Conference. We did better! As a result of proceeds from the Foundation’s fundraising events held in conjunction with the NCPDP conference, and the heartening response to the 1977 Society, we have reached 110% of our goal.
Read More